Two Clinical Trials Reveal Addition of Immunotherapy to Chemotherapy Regimen Increases Progression-Free Survival in Endometrial Cancer Patients
Society of Gynecologic OncologyThe results of two clinical trials, presented today at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer, showcased adding immunotherapy to standard chemotherapy resulted in significantly longer progression-free survival (PFS) among patients with advanced or recurrent endometrial cancer (EC).